Clinical Trial Update: Efficacy and Safety Study of RoActemra (Tocilizumab) in Participants With Rheumatoid Arthritis

View source ↗

Summary

This clinical trial update reports the efficacy and safety results of tocilizumab (RoActemra) in participants with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• RoActemra (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Status: COMPLETED